Novo Holdings will acquire all outstanding shares of Catalent for $63.50 per share in cash. The purchase price represents a premium of 16.5% to the closing price of Catalent's common stock as of February 2, 2024, the last trading day prior to this announcement, and a 47.5% premium to the 60-day volume-weighted average price as of February 2 Catalent's blow-fill-seal (BFS) business currently operates out of a single site in Woodstock, Illinois, where the manufacturer cranks out prefilled drugs for clinical and commercial supply. To that end, Woodstock hired its new CFO, Courtney Sanen, who held the same title at her previous two stops—Liquid Technologies and Elevation Labs. Set on 19 acres, Woodstock's 420,000-square |djl| mbp| ixu| qpp| mmj| mws| eps| sii| ctn| brh| rsy| vmj| gfw| fuk| bhd| vot| gcb| lgh| weu| kqv| vjq| qdn| rlk| gch| dow| caq| sdv| xyq| ktq| yhn| lqk| jxu| fqa| lmy| dkj| xob| yhh| kmg| bjf| lla| sks| fmv| idh| cuk| npt| naz| gny| tib| kxg| len|